Charles Schwab Investment Management Inc Vaxxinity, Inc. Transaction History
Charles Schwab Investment Management Inc
- $429 Billion
- Q1 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Vaxxinity, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 120,334 shares of VAXX stock, worth $30,083. This represents 0.0% of its overall portfolio holdings.
Number of Shares
120,334
Previous 120,334
-0.0%
Holding current value
$30,083
Previous $102,000
15.69%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding VAXX
# of Institutions
58Shares Held
12.2MCall Options Held
0Put Options Held
0-
Adage Capital Partners Gp, L.L.C. Boston, MA3MShares$750,0000.0% of portfolio
-
Black Rock Inc. New York, NY2.62MShares$655,7630.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.41MShares$602,9190.0% of portfolio
-
Geode Capital Management, LLC Boston, MA879KShares$219,6350.0% of portfolio
-
State Street Corp Boston, MA799KShares$199,8180.0% of portfolio
About Vaxxinity, Inc.
- Ticker VAXX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 112,150,000
- Market Cap $28M
- Description
- Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology and coronaviruses in the United States. The company engages in developing UB-311 that targets toxic forms of aggregated amyloid-b in the brain to fight Alzheimer's disease (AD) that is in phase 2 clinical trial; UB-312 that...